Limnopharma Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
5
Limnopharma General Information
Description
Developer of pharmaceutical research drugs designed to create new treatments for degenerative retinal disorders. The company offers small-molecule drug candidates derived from natural compounds with neuroprotective and anti-inflammatory properties, enabling patients with retinal diseases and ophthalmology specialists to access non-invasive therapeutic options that aim to preserve vision and improve long-term eye health.
Contact Information
Website
www.limnopharma.comCorporate Office
- Queen Mary Building, Bailén-Motril Highway
- Bailén-Motril Highway, South/North, Parc 102
- 18210 Granada
- Spain
Corporate Office
- Queen Mary Building, Bailén-Motril Highway
- Bailén-Motril Highway, South/North, Parc 102
- 18210 Granada
- Spain
Limnopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 01-Feb-2025 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2021 | Completed | Clinical Trials - General | |||
| 1. Early Stage VC | 23-May-2019 | $140K | $140K | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Limnopharma Comparisons
Industry
Financing
Details
Limnopharma Competitors (6)
One of Limnopharma’s 6 competitors is Mito.Tech, a Venture Capital-Backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mito.Tech | Venture Capital-Backed | London, United Kingdom | ||||
| Miramoon Pharma | Accelerator/Incubator Backed | San Sebastián, Spain | ||||
| SparingVision | Venture Capital-Backed | Paris, France | ||||
| Alkeus Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| InflammX | Venture Capital-Backed | Tampa, FL |
Limnopharma Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Medex Partners | Venture Capital | Minority | ||
| Fondation de l'Avenir | Government | |||
| Genesis Ventures | Venture Capital | Minority | ||
| Covirán | Corporation | Minority | ||
| Genesis Biomed | Venture Capital | Minority |
Limnopharma FAQs
-
When was Limnopharma founded?
Limnopharma was founded in 2019.
-
Where is Limnopharma headquartered?
Limnopharma is headquartered in Granada, Spain.
-
What industry is Limnopharma in?
Limnopharma’s primary industry is Drug Discovery.
-
Is Limnopharma a private or public company?
Limnopharma is a Private company.
-
What is Limnopharma’s current revenue?
The current revenue for Limnopharma is .
-
How much funding has Limnopharma raised over time?
Limnopharma has raised $140K.
-
Who are Limnopharma’s investors?
Medex Partners, Fondation de l'Avenir, Genesis Ventures, Covirán, and Genesis Biomed have invested in Limnopharma.
-
Who are Limnopharma’s competitors?
Mito.Tech, Miramoon Pharma, SparingVision, Alkeus Pharmaceuticals, and InflammX are some of the 6 competitors of Limnopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process